Scott A. Canute

Insider Reports History

Location
Burlington, MA
Signature
/s/ Brian J. Shea, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott A. Canute:

Company Role Class Num Shares Value Price $ Report Date Ownership
Oncorus, Inc. Director Stock Option (right to buy) 12,500 23 Jun 2022 Direct
Flexion Therapeutics Inc Director Common Stock 0 $8.50 19 Nov 2021 Direct
Flexion Therapeutics Inc Director Stock option (right to buy) 0 19 Nov 2021 Direct

Insider Reports Filed by Scott A. Canute

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919122039082-canute-scott-a-2022-06-23 Oncorus, Inc. 23 Jun 2022 1 $0 4 Director 24 Jun 2022, 06:39
/report/000120919121065715-canute-scott-a-2021-11-19 Flexion Therapeutics Inc 19 Nov 2021 9 -$76,500 4 Director 19 Nov 2021, 09:10
/report/000120919121043554-canute-scott-a-2021-06-24 Flexion Therapeutics Inc 24 Jun 2021 2 $0 4 Director 28 Jun 2021, 18:38
/report/000120919121041613-canute-scott-a-2021-06-16 Oncorus, Inc. 16 Jun 2021 1 $0 4 Director 17 Jun 2021, 17:54
/report/000120919121041603-canute-scott-a-2020-12-11-restatement Oncorus, Inc. 11 Dec 2020 1 $0 4/A Director 17 Jun 2021, 17:45